Study Dosed With (123I-mIBG) for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event
- First Posted Date
- 2008-11-05
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 471
- Registration Number
- NCT00785044
- Locations
- ๐บ๐ธ
GE Healthcare, Princeton, New Jersey, United States
Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers
Phase 2
Completed
- Conditions
- First Posted Date
- 2008-11-05
- Last Posted Date
- 2009-12-07
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 78
- Registration Number
- NCT00785759
- Locations
- ๐ณ๐ด
GE Healthcare, Oslo, Norway
Recurrence of Bladder Cancer After Transurethral Resection With Hexvix
- First Posted Date
- 2008-11-05
- Last Posted Date
- 2015-04-24
- Lead Sponsor
- GE Healthcare
- Registration Number
- NCT00785694
- Locations
- ๐ซ๐ท
GE Healthcare Medical Diagnostics, Velizy Cedex, Morane Saulnier, France
Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as Part of Their Routine Medical Care
Completed
- Conditions
- First Posted Date
- 2008-10-31
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 885
- Registration Number
- NCT00783302
- Locations
- ๐บ๐ธ
GE Healthcare, Princeton, New Jersey, United States
A Prospective Surveillance Trial to Evaluate the Safety of Optison in Clinical Practice.
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2012-06-12
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 1039
- Registration Number
- NCT00730964
- Locations
- ๐บ๐ธ
GE Healthcare, Princeton, New Jersey, United States
Evaluation Of The GE Monitor Product Line
Withdrawn
- Conditions
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2017-08-08
- Lead Sponsor
- GE Healthcare
- Registration Number
- NCT00730119
- Locations
- ๐บ๐ธ
GE Healthcare, Tampa, Florida, United States
Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma
- Conditions
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2009-11-09
- Lead Sponsor
- GE Healthcare
- Registration Number
- NCT00730444
- Locations
- ๐บ๐ธ
GE Healthcare, Princeton, New Jersey, United States
Preoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep Stages
Completed
- Conditions
- First Posted Date
- 2008-07-10
- Last Posted Date
- 2011-04-28
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 103
- Registration Number
- NCT00712946
- Locations
- ๐ซ๐ฎ
Department of Anesthesiology and Intensive Care, Turku University Hospital, Turku, Finland
Comparative Study of Phototherapy for Hyperbilirubinemia
Not Applicable
Completed
- Conditions
- Interventions
- Device: LED fiberoptic blanket phototherapy (BiliSoft blue LED fiberoptic blanket phototherapy)Device: Metal halide phototherapy (Spot PT metal halide phototherapy)Device: LED bank phototherapy (Natus neoBlue LED bank phototherapy)Device: Metal halide plus LED fiberoptic blanket phototherapy (BiliSoft and Spot PT)
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2009-01-13
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 82
- Registration Number
- NCT00635375
- Locations
- ๐บ๐ธ
Christiana Hospital, Newark, Delaware, United States
๐บ๐ธUniversity of Tennessee, Knoxville, Tennessee, United States
Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer
Completed
- Conditions
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2014-08-25
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 283
- Registration Number
- NCT00634621
- Locations
- ๐ช๐ธ
GE Healthcare, Madrid, Spain
ยฉ Copyright 2024. All Rights Reserved by MedPath